HAI EUROPE PUBLICATIONS
LIST
2002
(updated 20 November 2002)
Newsletters
Publications
Briefing papers
Press releases
- HAI News
The network's global newsletter featuring international
health issues and news from HAI groups worldwide. Produced 4 times per year
by the HAI office in Sri Lanka. Subscriptions can be ordered directly from
HAI News.
Click below to see the full text of the following issues:
April-June 2002,
July-September 2001, April
2000, February/March 2000, December
1999, August 1999, June
1999, February 1999, December
1998
HAI News subscription rates (annual):
US$ 10 developing countries
US$ 20 developed countries
-
HAI-Lights
The regional newsletter for
HAI partners active in Europe and North America. It is produced 3
times a year by the HAI Europe office to support the work of Health Action
International and participants of the HAI Europe network.
Click here to see a full list of the
current and past issues and their cover stories.
New October 2002 issue:
This issue's cover story, by Alan Cassels, is a report on the World
Health Assembly 2002. He has given his article the
title 'The importance of what wasn't said in Geneva'. Click
here to see the issue (PDF file).
If you cannot download the above issues and would like
to receive a printed version of HAI Lights please click
here to send an e-mail to the HAI Europe office for information.
PUBLICATIONS
-
Sustaining Access to
medicines in Europe: the Coming Crisis.
Report of the HAI Europe/Medico International Seminar held 2 November
2001. The meeting emphasised access issues affecting Europe now and in the
near future. (HAI Europe 2002)
-
Providing Prescription
Medicine Information to Consumers: Is there a role for direct-to-consumers
promotion ?
Report of the HAI Europe /EPHA symposium held in January 2002 in Brussels.
The symposium was held in advance of an EC proposal to open up the EU to
prescription drug advertising; participants shared perspectives on the proposal
and its possible impact on public health in Europe.
- Public-Private
'Partnerships' : Addressing Public health Needs or Corporate Agendas?
Report on the HAI Europe/BUKO Pharma-Kampagne Seminar held 3 November 2000.
The publication highlights risks related to WHO's and others' involvement
in public-private partnerships (also available as a Word
document). (HAI Europe)
- Moving
in from the Margin: Increasing Consumer Involvement in the Formulation
and Implementation of National Drug Policies Report of the HAI Regional Workshop
on Networking for Rational Drug Use in Southern Africa. 31 May - 5 June 1998,
Johannesburg, South Africa.
Report of a June 1998 workshop in South Africa, where 34 participants from
11 African countries examined the strengths and weaknesses of national drug
policy development and implementation, identified ways to reduce irrational
drug use and formulated strategies for improving consumer and NGO participation
in national drug policies and for increasing rational drug use in Africa.
(HAI Africa/HAI Europe 1999)
Price: Euro 16.00, US$ 17.50
- The Ties That Bind:
weighing the risks and benefits of pharmaceutical industry sponsorship
(seminar report) see campaigns
page
Public funding for health care initiatives is steadily declining. More and
more NGOs must compete for a dwindling pot of money. As a result, many health-related
NGOs are debating whether or not to accept funding from the pharmaceutical
industry. But is this path so unavoidable and so easily managed into a win-win
situation for both industry and health-promoting NGOs? HAI Europe held a one-day
seminar to explore this issue and promote discussion between NGOs that do
accept industry funding and those who are opposed to it. This report describes
the presentations made during the day and the lively debate among the participants.
It highlights specific concerns surrounding industry sponsorship and some
of its possible consequences for NGOs. (HAI Europe 1999)
Price: Euro 9.00, US$ 10.00
- Blurring the Boundaries: New Trends in Drug Promotion
(B. Mintzes) (Click here to view
full text) Today there is a deliberate blurring of boundaries between
drug promotion and objective information on the one hand and the public and
private sector on the other. With shrinking public budgets for health and
social services, a new climate of "partnership" with industry has emerged
without a great deal of examination of what these partnerships may mean. This
publication explores the implications this situation has on consumer health,
access to appropriate health services and the information on which treatment
decisions are based. It also sets out a series of recommendations on how various
players involved in drug regulation can work to control drug promotion effectively
in order to encourage more rational drug use. (HAI Europe 1998)
Price: Euro 11.00, US$ 12.50
- Developing Essential Drugs
Policies: A Guide for NGOs
Essential drugs policies based on the WHO concept enable NGOs to use their
limited resources to manage drugs effectively and meet priority needs. An
essential drugs policy can help NGOs provide improved information, education
and training, as well as more efficient supply, storage and distribution of
drugs. While many NGOs have advocated the adoption of the WHO essential drugs
concept by governments, only a few have integrated it into their own practice.
This booklet aims to help change that. It offers practical advice for NGOs
interested in developing and implementing essential drugs policies for their
organisation. (HAI Europe 1998)
Price: Free of charge
- Fragile Economies, Flooded
Markets - Networking for Rational Drug Use in Africa
Report on the HAI Eastern Africa training workshop "Promoting Rational Drug
Use in the Community" which was held in Nairobi, Kenya from 14-19 March, 1997.
While pharmaceuticals can play a key role in improving health, their benefits
remain largely unknown to millions of African consumers. Instead, drugs often
contribute to serious health problems on the continent due to misdiagnosis,
incorrect self-medication and poor quality of drugs. Many Africans lack access
to the most essential drugs and scarce resources are often spent on ineffective
and expensive treatments. This report summarises the participants' presentations,
conclusions and plans for the future. (HAI Africa/HAI Europe 1997)
Price: Euro 17.50, US$ 17.50
- Problem Drugs Pack (A.Chetley)
Information pack on various categories of problem drugs and special prescribing
needs for women, children and the elderly. Highlights examples of unethical
& double standards in marketing. Special loose-leaf sections for teaching
and campaign work (HAI Europe 1994)
Price: Euro 16.00, US$17.50
- Problem Drugs (book form) (A.Chetley)
Book version of above Pack (ZED Books 1995). Also available in Russian.
Price: Euro 18.00, US$ 20.00
- Médicaments à Problèmes (A.
Chetley) read more about the book in English or
French
French translation of the book version of Problem Drugs
with new information about the situation in Francophone Africa (HAI Europe
1999)
Price: Euro 20, US$20
- Medicamentos Problema (A.Chetley)
Spanish translation of the book version of Problem Drugs Pack (AIS 1995)
Price:Euro 14.00, US$ 15.00
- International Journal of Risk and Safety in Medicine
Special Issue featuring papers from international authors on how secrecy
and lack of transparency and accountability in drug regulation undermine public
health (IOS Press 1997),
Price: Euro 22.50, US$ 25.00
- Power, Patents and Pills
Seminar Report on the consequences of GATT/WTO for public health and
access to essential drugs.
A number of international trade agreements have strong implications for public
health. Health Action International (HAI) Europe and BUKO Pharma-Kampagne
held a seminar on the GATT/World Trade Organization, Pharmaceutical Policies
and Essential Drugs. This seminar explored the consequences of the GATT (General
Agreement on Tariffs and Trade) and the newly created World Trade Organization
(WTO) for public health and access to pharmaceuticals, especially essential
drugs. The publication summarises the seminar's presentations and discussion.
It aims to provide a better understanding of the GATT and WTO and their effects
on pharmaceutical policies and essential drugs. (HAI Europe 1997)
Price: Euro 7.50, US$ 7.50
- Dipyrone: a Drug No One Needs
Critical review of dipyrone incl. bibliography and list of brand name
products containing dipyrone (HAI-Europe/BUKO 1989).
Price: Euro 9.00, US$ 10.00
- A Healthy Business (A. Chetley)
Traces the campaign for a more rational use of drugs and examines the
response of the industry to its critics (ZED books,1990)
Price: Euro 15.75, US$ 17.50
- The Provision and Use of Drugs in Developing Countries
(A. Hardon et al.)
Annotated bibliography of studies on drug use. Includes a review of policy
implications (University of Amsterdam/HAI 1991)
Price: Euro 15.00, US$ 16.25
- Promoting Health or Pushing Drugs ?
A critical examination of marketing of pharmaceuticals (HAI Europe 1992)
Price: NLG 7.00, US$7.50
- Med-Sense
A HAI product promoting critical attitudes towards medicines and encouraging
the rational use of drugs. Comes in the form of a pill box. Available in English,
French, Spanish, Dutch; limited numbers available in Germany, Flemish, Russian,
Latvian, Lithuanian, Polish. (HAI Europe 1992)
Price: Euro 2.00 (5 boxes for Euro 8.00, 10 boxes for Euro10.00)
- Power and Dependence ( by Charles Medawar)
Discusses safety of medicines from a consumer perspective with special
reference to benzodiazepine tranquillisers (Social Audit 1992)
Price: Euro 17.50, US$ 18.75
- Health and Disease in Developing Countries (Kari
S. Lankinen et al.)
Health issues and specific diseases are investigated from the wider perspective
of development in general, includes strategies for international cooperation.
(Macmillan 1994)
Price: Euro16.00, US$17.50
- A Healthy Balance? Women and Pharmaceuticals
An international collection of articles on women and drugs covering: drugs
in pregnancy, psychotropics, contraceptive research, quality of care, STDs
and medicalisation of women's lives. (Women's Health Action Foundation 1995)
Price: Euro 11.00, US$ 12.50
- Deception by Design - Pharmaceutical Promotion
in the Third World (Joel Lexchin)
Exposes double standards employed by the pharmaceutical industry in their
marketing and promotional practices in developing versus industrialised countries.
(Consumers International (CI ROAP) 1995)
Price: Euro 11.00, US$ 12.50
Direct-to-Consumer Prescription Drug Advertising:
the European Commission's Proposal for Legislative Change (Barbara
Mintzes).
Click here for English version;
French version; German
version
Briefing document prepared for the DTCA seminar (10 January 2002) in Brussels.
(HAI, December 2001)
Health,
Pharma and the EU: A briefing for Members of the European Parliament
on DIRECT-TO-CONSUMER DRUG PROMOTION (Charles Medawar) (HAI, January 2002).
Also available in French.
To order any of the listed
publications contact:
HAI
Europe, Jacob van Lennepkade 334-T, 1053 NJ Amsterdam, The Netherlands
Tel: (+31 20) 683 3684 / Fax: (+31 20) 685 5002 / E-mail: info@haiweb.org
Payments can be made in Euros using
credit cards (Mastercard, Visa) or, for larger orders, through bank transfer.
Payment instructions will be given at time of dispatch. N.B. : postage not included.
Please indicate on order if books are to be sent by airmail or surface mail
and rates will be advised.
Return to
HAI Homepage